Scientists at Michigan Medicine have made a significant breakthrough in treating nonalcoholic fatty liver disease (NAFLD), a ...

Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.

Seven patients had ascites and edema, with obvious clinical signs and laboratory tests of liver function indicating severe functional impairment warranting diagnoses of cirrhosis of the liver.

The risk of developing liver cancer is increased in people who have cirrhosis, a disease in which healthy liver tissue is ...

Researchers describe successful tumor removal through the use of immunotherapy and targeted radiation therapy (TARE), in a patient previously considered ineligible for the procedure.

The root cause of cirrhosis is the accumulation of fat in liver cells, so new GLP-1 drugs targeting obesity could potentially prove useful, but for now there is no medical treatment, Aminian said ...

you'll need to take medicines to prevent your body from rejecting the new organ. Because these drugs suppress your immune system, they can increase your risk for infection. Can cirrhosis be reversed?

Then on Monday, Akero Therapeutics reported outstanding results from a study of its drug efruxifermin that demonstrated a statistically significant reversal of cirrhosis in patients with severe MASH.

Future research is needed to study the new generation of anti-obesity medications and whether they can provide similar benefits in this patient population. More information: Long-term liver outcomes ...

The results are published in Nature Medicine. Ali Aminian ... effective treatment for MASH without cirrhosis. Future research is needed to study the new generation of anti-obesity medications ...